Skip to main content

Peer Review reports

From: Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial

Original Submission
21 Nov 2023 Submitted Original manuscript
2 Feb 2024 Reviewed Reviewer Report - Marouf Alhalabi
9 Feb 2024 Reviewed Reviewer Report
23 Feb 2024 Author responded Author comments - Feihu Bai
Resubmission - Version 2
23 Feb 2024 Submitted Manuscript version 2
24 Feb 2024 Author responded Author comments - Feihu Bai
Resubmission - Version 3
24 Feb 2024 Submitted Manuscript version 3
27 Feb 2024 Reviewed Reviewer Report
1 Mar 2024 Reviewed Reviewer Report - Marouf Alhalabi
18 Mar 2024 Author responded Author comments - Feihu Bai
Resubmission - Version 4
18 Mar 2024 Submitted Manuscript version 4
3 Apr 2024 Reviewed Reviewer Report - Marouf Alhalabi
5 Apr 2024 Author responded Author comments - Feihu Bai
Resubmission - Version 5
5 Apr 2024 Submitted Manuscript version 5
Publishing
9 Apr 2024 Editorially accepted
12 Apr 2024 Article published 10.1186/s12876-024-03225-8

You can find further information about peer review here.

Back to article page